Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19

Background: Efficient healthcare based on prognostic variables in hospitalised patients with COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase Plasminogen Activator Receptor (suPAR) was shown to predict respiratory failure, kidney injury, and clinical outcome in...

Descripción completa

Detalles Bibliográficos
Autores principales: Enocsson, Helena, Idoff, Cornelia, Gustafsson, Annette, Govender, Melissa, Hopkins, Francis, Larsson, Marie, Nilsdotter-Augustinsson, Åsa, Sjöwall, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674575/
https://www.ncbi.nlm.nih.gov/pubmed/34926532
http://dx.doi.org/10.3389/fmed.2021.791716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674575/
https://www.ncbi.nlm.nih.gov/pubmed/34926532
http://dx.doi.org/10.3389/fmed.2021.791716

Ejemplares similares